Skip to main content

Advertisement

Log in

Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study)

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aims

The aim of the study was to evaluate and compare continuous subcutaneous insulin infusion (CSII) use in pediatric and adult age groups.

Methods

Data were collected with a questionnaire sent by e-mail to CSII-experienced Diabetes Centers. The questionnaire assessed: (1) number of CSII-treated patients; (2) patient demographic data and characteristics; (3) structure and organization of Diabetes Centers providing CSII therapy; (4) pump characteristics (conventional pump, sensor-augmented pump); and (5) CSII dropouts.

Results

A total of 217 out of 1093 Italian centers participated: 51 pediatric (23.5 %) and 166 (76.5 %) adult centers (AP). Compared to a survey performed in 2005, there was a significant increase in the number of pediatric units when compared to adult units (112 vs 37 %, respectively, p < 0.05). Pediatric age is characterized by a greater concern for quality of life and injections, and a higher dropout rate (10.6 vs 8.9 %) mainly related to pump wearability and site reactions. A complete diabetes-care team is associated with a superior use of technology (fewer dropouts, increased CGM and advanced bolus use) which is, however, still used in a small percentage of patients.

Conclusions

In Italy, the number of CSII-treated pediatric patients (PP) is growing more significantly when compared to adults. Only 60 % of all patients are using advanced functions and 20 % are using CGMs continuously. This confirms the great interest in diabetes technology that is growing in pediatric diabetologists. However, much improvement is warranted in the organization and specialized training of pediatric, adult and transitional facilities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Pickup JC (2012) Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 366:1616–1624

    Article  CAS  PubMed  Google Scholar 

  2. Dovc K, Telic SS, Lusa L et al (2014) Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis. Diabetes Technol Ther 16:33–40

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mameli C, Scaramuzza AE, Ho J et al (2014) A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes. Acta Diabetol 51(2):205–210

    Article  CAS  PubMed  Google Scholar 

  4. Yeh HC, Brown TT, Maruthur N et al (2012) Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 157:336–347

    Article  PubMed  Google Scholar 

  5. Steineck I, Cederholm J, Eliasson B et al (2015) Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. BMJ 350:h3234

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ross PL, Milburn J, Reith DM, Wiltshire E, Wheeler BJ (2015) Clinical review: insulin pump-associated adverse events in adults and children. Acta Diabetol. doi:10.1007/s00592-015-0784-2

    Article  PubMed  Google Scholar 

  7. Pinelli L, Rabbone I, Salardi S et al (2008) Insulin pump therapy in children and adolescents with type 1 diabetes: the Italian viewpoint. Acta Biomed 79:57–64

    PubMed  Google Scholar 

  8. Frontoni S, Lapolla A, Ponziani MC et al (2014) Standard Italiani 2.0 AMD-SID per la cura del diabete mellito. ildiabeteonline.it

  9. Bruttomesso D, Laviola L, Lepore G et al (2015) Continuous subcutaneous insulin infusion in Italy: third national survey. Diabetes Technol Ther 17:96–104

    Article  PubMed  Google Scholar 

  10. Aiello A (2014) Il censimento delle strutture diabetologiche. VII Convegno Nazionale Fondazione AMD. http://www.infodiabetes.it/pages/informazioni/le_relazioni_del_25_ottobre_2014/

  11. Bruttomesso D, Costa S, Crazzolara D et al (2006) Continuous subcutaneous insulin infusion (CSII) in Italy. Diabetes Res Clin Pract 74(Suppl 2):S130–S134

    Article  CAS  Google Scholar 

  12. Rabbone I, Minuto N, Scaramuzza A et al (2015) Pump breakdown or malfunctions in a large cohort of Italian children and adolescents with type 1 diabetes using insulin pump therapy. Diabetes Technol Ther 17:A10–A11

    Google Scholar 

  13. Cameron FJ, Amin R, de Beaufort C, Codner E, Acerini CL (2014) ISPAD clinical practice consensus guidelines 2014. Diabetes in adolescence. Pediatr Diabetes 15(Suppl 20):245–256

    Article  CAS  PubMed  Google Scholar 

  14. Peters A, Laffel L, American DATWG (2011) Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care 34:2477–2485

    Article  PubMed  PubMed Central  Google Scholar 

  15. Renard E (2010) Insulin pump use in Europe. Diabetes Technol Ther 12(Suppl 1):S29–S32

    PubMed  Google Scholar 

  16. Miller KM, Foster NC, Beck RW et al (2015) Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 38:971–978

    Article  PubMed  Google Scholar 

  17. Sulmont V, Lassmann-Vague V, Guerci B (2011) Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001. Diabetes Metab 37(1):59–63

    Article  CAS  PubMed  Google Scholar 

  18. Karges B, Rosenbauer J, Kapellen T et al (2014) Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012. PLoS Med 11:e1001742

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lombardo F, Scaramuzza AE, Iafusco D (2012) Failure of glycated hemoglobin drop after continuous subcutaneous insulin infusion initiation may indicate patients who discontinue: a 4-year follow-up study in children and adolescents with type 1 diabetes. Acta Diabetol 49(Suppl 1):S99–S105

    Article  PubMed  Google Scholar 

  20. Beck RW, Tamborlane WV, Bergenstal RM et al (2012) The T1D Exchange clinic registry. J Clin Endocrinol Metab 97:4383–4389

    Article  CAS  PubMed  Google Scholar 

  21. Lenhard MJ, Reeves GD (2001) Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 161:2293–2300

    Article  CAS  PubMed  Google Scholar 

  22. Liebl A, Henrichs HR, Heinemann L et al (2013) Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol 7:500–519

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tamborlane WV, Beck RW et al (2008) Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359:1464–1476

    Article  PubMed  Google Scholar 

  24. Dovč K, Bratina N, Battelino T (2015) A new horizon for glucose monitoring. Horm Res Paediatr 83(3):149–156

    Article  PubMed  Google Scholar 

  25. NICE (2008) Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. NICE technology appraisal guidance 151

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to R. Bonfanti.

Ethics declarations

Conflict of interest

D.B. has received lecture fees from Eli Lilly, LifeScan, Roche Diagnostics and Sanofi Aventis and has provided advisory services to Abbott. L.L. has received speaker fees from Abbott, Astra Zeneca, Bayer, Eli Lilly, MSD, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi Aventis and Takeda and has provided advisory services to Astra Zeneca, Eli Lilly, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi Aventis and Takeda. G.L. has received speaker fees from Medtronic, Sanofi Aventis and Eli Lilly and has provided advisory services to Novo Nordisk. R.B. has received fees for consulting from Roche Diagnostics, Eli Lilly and Sanofi Aventis and a travel grant from Animas and has provided advisory services to Medtronic. A.C. has received speaker fees from Medtronic. V.D.B. has received speaker fees from Eli Lilly, Menarini and Sanofi Aventis. A.G. has attended conferences organized by Eli Lilly as a contributor. G.G. has provided advisory services to Eli Lilly, Abbott and Becton–Dickinson and received speaker fees from Menarini, Roche Diagnostics and Medtronic. I.R. has received speaker fees from Eli Lilly, Roche Diagnostics and Sanofi Aventis. R.S. has received speaker fees from Eli Lilly and has provided advisory services to Roche Diagnostics and Abbott. L.B. and D.I. declare no competing financial interests exist. The remaining authors declare that they have no conflict of interest.

Human and animal rights disclosure

This article does not contain any studies with human or animal subjects performed by the any of the authors.

Informed consent

None.

Additional information

Managed by Antonio Secchi.

R. Bonfanti and G. Lepore have equally contributed to the paper.

A complete list of members of the Italian Study Group on Diffusion of CSII can be found in the “Appendix,” and they have to be considered co-authors.

Appendix: Members of the Italian Study Group on Diffusion of CSII

Appendix: Members of the Italian Study Group on Diffusion of CSII

All the following primary investigators and clinical centers, listed by region or city (affiliation), participated in this study:

Abruzzo

Atri (TE), V. Montani and P. Colleluori; Avezzano (AQ), V. Paciotti and P. Alfidi; Castel di Sangro (AQ), J. Grosso; Chieti, S. Tumini and P. Cipriano (Diabetologia Pediatrica) and E. Vitacolonna and G. Di Vieste (Diabetologia Universitaria Policlinico); Lanciano (CH), A. Minnucci and D. Antenucci; Pescara, G. La Penna and M. Taraborrelli; Sulmona (AQ), B. Macerala.

Basilicata

Potenza, G. Citro.

Calabria

Cosenza, G. De Morelli; Catanzaro, A. Gnasso and C. Irace (Malattie del Metabolismo, Università degli Studi Magna Graecia) and F. Citriniti (Diabetologia); Crotone, N. Lazzaro; Locri (RC), M. Bruzzese and F. Mammì; Paola (CS), F. De Berardinis and E. Santoro.

Campania

Avellino, G. Corigliano and M. Corigliano; Caserta, M. Parillo (Diabetologia UOC Geriatria ed Endocrinologia e Malattie del Ricambio AORN “S. Anna e S. Sebastiano”) and M. Schettino (Diabetologia UOC Medicina Interna AORN “S. Anna e S. Sebastiano”); Cava de’Tirreni (SA), V. Di Blasi and R. Fresa; Napoli, G. Annuzzi and L. Bozzetto (Diabetologia Università Federico II), V. Bassi and C. Santinelli (PO S.G. Bosco, ASL Na1-Centro), P. Buono and E. Mozzillo (Diabetologia Pediatrica Università Federico II), G. Corigliano and V. Russo (Diabetologia AID), E. De Feo (Diabetologia AORN A. Cardarelli), K. Esposito and M. Petrizzo (Seconda Università), A. Foglia (Ospedale dei Pellegrini), A. Gatti (Diabetologia Ospedale San Gennaro), S. Gentile and G. Guarino (Dipartimento di Medicina Clinica e Sperimentale, Seconda Università), and A. Zanfardino and S. Confetto (Diabetologia Pediatrica “G. Stoppoloni” Seconda Universita di Napolì); Salerno, C. Lambiase and A. Vitale.

Emilia Romagna

Bologna, S. Zucchini and G. Maltoni (Pediatria AOU di Bologna S. Orsola-Malpighi), G. Forlani and S. Moscatiello (Policlinico S. Orsola-Malpighi); Cesena, T. Suprani and M. Bensa; Ferrara, F. Tomasi and M. Monesi; Forlì, M. Nizzoli and S. Acquati; Guastalla-Correggio (RE), G. Chierici and B. Milli; Modena, L. Iughetti and B. Predieri (UO Pediatria Università Modena-Reggio Emilia) and R. Cavani and S. Romano (Servizio Diabetologico Azienda USL); Montecchio (RE), V. Manicardi and M. Michelini; Parma, M.C. Cimicchi and D. Ugolotti (Ambulatori Diabetologici Distretto), I. Zavaroni and A. Dei Cas (SS Endocrino-Metabolica, AOU Parma), E. Dall’Aglio and M. Papi (Malattie del Ricambio e Diabetologia, AOU Parma), and S.M. Tardio and M.C. Calderini (Trattamento intensivo del diabete, AOU Parma); Piacenza, S. Riboni and L. d’Amato (Pediatria) and D. Zavaroni and L. Gastaldi (Az. USL); Ravenna, A. Cirillo and V. Graziani (Pediatria) and P. Di Bartolo and F. Pellicano (Diabetologia AULS); Reggio Emilia, C. Di Seclì and V. Manicardi (AUSL) and S. Amarri and A. Lasagni (Pediatria, AO Santa Maria Nuova); Rimini, A. Marsciani and A. Pedini; Scandiano (RE), U. Pagliani and C. Rossi.

Friuli-Venezia Giulia

Monfalcone (GO), C. Tortul, B. Brunato, and R. Assaloni; Pordenone (PN), G. Zanette; Sacile (PN), P. Livolsi; Trieste, A. Petrucco and K. Tercelj (SO Distretto 1), E. Manca (ASS1 Triestina, Distretto 2), R. Candido and E. Tommasi (ASS 1Triestina, Distretto 3), and G. Tornese and E. Faleschini (UCO Clinica Pediatrica, IRCCS Burlo); Udine, L. Tonutti and S. Agus (SOC Endocrinologia e Metabolismo), M. Zanatta and A. Rosolen (AOU S. Maria della Misericordia), and A. Comici (SOC Pediatria, Ospedale San Antonio).

Lazio

Frascati (RM), F.M. Graziano and I. Misischi; Frascati (RM), P. Falasca; Gaeta (LT), F. Tuccinardi; Latina, G.P. Ricciardi and P. Di Masa (ASL Latina Distretto 1 UOSD), M. Ragonese and L. Cipolloni (Cavalieri di Malta, Diabetologia), R. Buzzetti, C. Moretti, and G. Leto (Ospedale S.M. Goretti—Polo Pontino Università Sapienza); Palidoro (RM), A. Crino` and S. Bocchini; Roma, P. Pozzilli and A.R. Maurizi (Università Campus Biomedico); P. Di Perna and M. Giuliano (ASL Roma C, Servizio di Endocrinologia e Diabetologia), S. Frontoni and I. Malandrucco (Ospedale S. Giovanni Calibita Fatebenefratelli, Servizio di Endocrinologia e Diabetologia), D. Pitocco (Università Cattolica Policlinico Gemelli, UO Diabetologia), R. Scalpone and F. Toscanella (IDI, IRCCS—UO Diabetologia), M. Cappa and D.Benevento (Ospedale Pediatrico Bambino Gesù, UOC Endocrinologia e Diabetologia), C. Ventura and V. Bonato (Ospedale Israelitico, UOS Endocrinopatie e Malattie del Metabolismo), M. De Bernardinis and M.G. Cavallo (Università Sapienza Policlinico Umberto I—+Servizio di Diabetologia), F. Leonetti (Università Sapienza Policlinico Umberto I, UOS Malattie Metaboliche e Diabetologia), S. Morano and E. Mandosi (Università Sapienza Policlinico Umberto I, Fisiopatologia Medica ed Endocrinologia, Clinica Medica V), E. Cicconetti and G. Ciampittiello (Policlinico Tor Vergata, UOC Diabetologia), D. Lauro, M.A. Marini and D. Sabato (Università Tor Vergata Policlinico Tor Vergata, UOC Endocrinologia e Diabetologia), G. Pugliese, A. Napoli (AO S. Andrea, Servizio Diabetologia), F. Massimiani and D. Fava (AO S. Giovanni Addolorata, UOSD Malattie Metaboliche e Diabetologia), P. Gargiulo and N. Mecca (Università Sapienza, Endocrinologia “A”), C. Tubili, M.R. Nardone and L. Morviducci (AO S. Camillo Forlanini, UOS di Diabetologia), M.L. Manca-Bitti and S. Arcano (Università Tor Vergata Policlinico Tor Vergata, Centro di Diabetologia Pediatrica), S. Leotta and C. Suraci (Ospedale Sandro Pertini, UOC Dietologia, Diabetologia e Malattie Metaboliche), F. Chiaramonte, F Strollo and N. Visalli (Polo Ospedaliero S. Spirito, Diabetologia e Dietologia); Terracina (LT), E. Forte and C. Palmacci; Viterbo, C. Arnaldi and D. Tosini.

Liguria

Genova, A. Corsi and P. Ponzani (ASL 3 Ospedale La Colletta), M. Patrone, R. Guido, and A. Aglialoro (ASL3 Ospedale Villascassi), G. Ghisoni and F. Fabbri (ASL 3 Poliambulatorio Nervi), C. Bordone, D. Maggi, and R. Cordera (UOC Malattie del Metabolismo e Diabetologia, IRCCS San Martino, Università, IST), and N. Minuto and G. D’Annunzio (Istituto Giannina Gaslini); Imperia, D. Speranza and M. Siri; La Spezia, S. Carro and A. Zappa (S.S.D. Centro Antidiabetico, Ospedale del levante ligure) and S. Parmigiani and S. Nieri (S.C. Pediatria, Ospedale del Levante Ligure); Pietraligure (SV), L. Briatore and G. Calvo.

Lombardia

Alzano Lombardo (BG), F. Querci; Bergamo, G. Lepore and R. Trevisan; Brescia, A. Girelli and S. Bonfadini (UO Diabetologia) and E. Prandi and B. Felappi (Clinica Pediatrica); Castellanza (VA), F. Locatelli and V. Fuso; Cinisello (MI), A. Rocca and E. Meneghini; Cologno Monzese (MI), C. Massafra and T. Terni; Como, P. Elli; Cremona, P. Ruggeri and E. Carrai; Cusano Milanino (MI), N. Musacchio and C.A. Lovagnini Scher; Desio (MI), G. Marelli and V. Vilei; Esine (BS), D. Richini and C. Inversini; Gallarate (VA), I. Franzetti and M. Bonacina; Mariano Comense (CO), A. Ciucci and L. Sciangula; Luino (VA), E. Duratorre; Milano, M. Bonomo and F. Bertuzzi (AO Niguarda Cà Granda), E. Chebat and M. Muratori (AO Sacco), A. Scaramuzza and G.V. Zuccotti (AO Sacco Clinica Pediatrica), P.M. Bollati and P. Colapinto (AO San Carlo Borromeo), E. Orsi and E. Palmieri (Fondazione IRCCS Cà Granda, Policlinico), A. Laurenzi and C. Molinari (Ospedale San Raffaele), A. Rigamonti, V. Favalli, and G. Frontino (Clinica Pediatrica Ospedale San Raffaele), and A. Veronelli and B. Zecchini (AO San Paolo); Paderno Dugnano (MI), A. Bianchi and G. Torchio; Pavia, E. Lovati; Piario (BG), G. Ghilardi; Rho (MI), R. Dagani and D. Carugo; Rozzano (MI), C. Berra and G. Favacchio; Sondrio, E. Fochesato and A. Pissarelli; Sesto San Giovanni (MI), L. Bucciarelli and M. Bulgheroni; Tradate (VA), L. Guerraggio and S. Zonca; Treviglio (BG), A.C. Bossi and D. Berzi; Vimercate (MI), I. Mangone and E. Cazzaniga.

Marche

Ancona (AN), R.A. Rabini and M. Boemi (UA Malattie Metaboliche e Diabetologia, INRCA), E. Faloia and M. Boscaro (Clinica Endocrinologica, Ospedali Riuniti), and G. Sternari, A. Iannilli, and V. Cherubini (Diabetologia Pediatrica, Ospedale Salesi); Camerino (MC), N. Busciantella Ricci and M.G. Cartechini; Macerata (MC), A.M. Tesei and G. Maolo; San Benedetto del Tronto e Ascoli Piceno (AP), M. Galetta and G. Vespasiani; Senigallia (AN), G. Tinti and S. Manfrini.

Molise

Campobasso, A. Aiello and S. Di Vincenzo; Termoli (CB), C. Vitale and P. Di Caro.

Piemonte

Alessandria, R. Lera and A. Secco; Carmagnola (TO), A. Lesina and F. Romeo; Chieri (TO), C. Origlia and C. Giorda; Chivasso (TO), A.M. Chiambretti and R. Fornengo; Cuneo, V. De Donno and F. Gallarotti; Nichelino (TO), R. Manti and L. Marafetti; Novara, F. Cadario and S. Savastio; Novi Ligure (AL), P. Barbieri; Torino, P. Massucco and A. Alì (S. Luigi di Gonzaga), C. Gottero (Ospedale Maria Vittoria), M. Degiovanni, S. Bertaina, G. Grassi, and G. Maghenzani (Citta della Salute e della Scienza), and MG Ignaccolo and D. Tinti (Endocrinologia e Diabetologia Pediatrica, AO Città della Salute e della Scienza di Torino); Tortona (AL), F. Fontana.

Puglia

Bari, F. Giorgino and G. Stefanelli (Endocrinologia Università), L. Cavallo and C. Zecchino (Pediatria Università), and E. Piccinno and F. Ortolani (Ospedale Pediatrico Giovanni XXIII); Brindisi, F. Gallo and F. Moramarco; Casarano (LE), A. Marino and G. Sparasci; Fasano (BR), G. Mileti; Foggia, O. Lamacchia and G. Picca; Francavilla Fontana (BR), M.S. Coccioli; Gallipoli (LE), F. Micale; Lecce, R. Serra and I. Romano; Mola (BA), T. Savino; S. Giovanni Rotondo (FG), S. De Cosmo and A. Rauseo (Endocrinologia) and M. Delvecchio and R. Lapolla (Pediatria); Taranto, A.F. Braione; Trani (BT), G. Papagno.

Sardegna

Cagliari, M. Baroni, M, Melis, and E. Cossu (Diabetologia Università di Cagliari) and M. Songini and V.M. Cambuli (Ospedale San Michele AO).

Sicilia

Catania, D. Lo Presti and T.A. Timpanaro (AOU Policlinico, Diabetologia Pediatrica), A. Chiavetta and M.R. Garofalo (UO Diabetologia), and L. Tommaselli and A. Tumminia (Endocrinologia, Ospedale Garibaldi Nesima, Università); Marsala, A.M. Scarpitta; Messina, A. Di Benedetto and L. Giunta (AOU Policlinico, Medicina Interna) and F. Lombardo andG. Salzano (UOCClinica Pediatrica); Palermo, F.Cardella and R. Roppolo (UOS Diabetologia Pediatrica); Partinico (PA), V. Provenzano and M. Fleres.

Toscana

Empoli, S. Migliorini and A. De Luca; Firenze, A. Leopardi and C. Beltrami (Diabetologia ASL 10), S. Toni, G. Guasti, and L. Lenzi (AOU Meyer), and C. Lamanna and E. Mannucci (AOU Careggi); Livorno, S. Lucchesi and G. Dicianni; Pisa, M. Aragona and S. Del Prato; G. Federico and B. Marchi.

Trentino Alto Adige

Bolzano (BZ), B. Fattor and J. Eisath (Ospedale Centrale) and B. Pasquino, P. Reinstadler, and P. Kaufmann (Dipartimento di Pediatria); Merano (BZ), G. Incelli and S. Rauch; Trento, T. Romanelli (Ospedale Santa Chiara, Diabetologia Adulti) and V. Cauvin and R. Franceschi (Ospedale S. Chiara, Diabetologia Pediatrica).

Umbria

Città di Castello (PG), C. Soldani and R. Scattoni; Perugia, R. Norgiolini and R. Celleno (AO “Santa Maria della Misericordia,” Clinica Pediatrica) and E. Torlone and G.B. Bolli (AO “Santa Maria della Misericordia,” Diabetologia); Spoleto (PG), C. Lalli and M. Scarponi.

Valle d’Aosta

Aosta: A. Bobbio and M. Bechaz.

Veneto

Bassano del Grappa (VI), A. Pianta and A. Marangoni; Belluno, C.N. Aricò and C. Alagona; Castelfranco Veneto (TV), L. Confortin and E. Rossi; Chioggia, A. Boscolo Bariga and A. Nogara; Cittadella (PD), M. Bettio and V. Frison; Conegliano Veneto (TV), G.L. Guidoni; Contarina (VE), C. Fongher; Dolo-Mirano (VE), M.L. Contin, A. Cosma, and S. Vianello; Legnago (VR), L. Bondesan and A. Morea; Montebelluna (TV), A. Volpi and A. Coracina; Monselice (PD), G. Panebianco; Montecchio Maggiore (VI), S. Lombardi and S. Costa; Padova, E. Cipponeri, M. Vedovato, and R. Scotton (Malattie del Metabolismo, Dipartimento Medicina Interna-DIMED, Università), C.M. Monciotti and A. Galderisi (Cl. Pediatrica, Università), and M.G. Dalfrà and A. Lapolla (UO Diabetologia e Dietetica, Università); Portogruaro-S. Donà di Piave (VE), M. Zanon; Rovigo, G. Lisato and F. Mollo; Schio (VI), F. Calcaterra and M. Miola; Treviso, A. Paccagnella and M. Sambataro; Venezia, E. Moro; Verona (VR), M. Trombetta and C. Negri (Azienda Ospedaliera Universitaria Integrata) and A. Sabbion and C. Maffeis (Pediatria, ULSS20 e Università); Vicenza (VI), M. Strazzabosco and C.A. Mesturino (Ospedale Civile) and R. Mingardi (Casa di Cura Villa Berica).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bonfanti, R., Lepore, G., Bozzetto, L. et al. Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study). Acta Diabetol 53, 403–412 (2016). https://doi.org/10.1007/s00592-015-0810-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-015-0810-4

Keywords

Navigation